Alumis Inc. (NASDAQ:ALMS) is one of the new stocks on the rise. On January 21, Chardan initiated coverage of Alumis with a Buy rating and a $37 price target driven by the significant potential of the ...

Alumis Inc. (NASDAQ:ALMS) is one of the 11 Best New Penny Stocks to Buy Right Now. On May 21, Alumis Inc. (NASDAQ:ALMS) reported that it has completed its merger with ACELYRIN, Inc. As part of this ...

Alan Colowick, a director at $ALMS, bought 16,104 shares of the company on 04-01-2025 for an estimated $112,309. This trade was reported by Quiver Quantitative using ...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...

We recently published a list of Thursday’s 10 Worst-Performing Stocks. In this article, we are going to take a look at where Alumis Inc. (NASDAQ:ALMS) stands against other Thursday’s worst-performing ...

Fintel reports that on January 21, 2026, Chardan Capital initiated coverage of Alumis (NasdaqGS:ALMS) with a Buy recommendation. Analyst Price Forecast Suggests 39.23% Upside As of January 14, 2026, ...

Alumis Inc. (NASDAQ: ALMS) stock is trading higher on Tuesday, with a session volume of 4.33 million compared to the average volume of 1.02 million as per data from Benzinga Pro. Alumis on Tuesday ...

Shares of Alumis (NASDAQ:ALMS) traded ~14% higher in the premarket on Tuesday after the California-based biopharma announced a collaboration and licensing agreement with Japanese drugmaker Kaken ...

In addition to Chardan Capital, Alumis Inc. also received a Buy from TipRanks – Google’s Google Biotechnology in a report issued on January 15. However, today, TipRanks – OpenAI reiterated a Hold ...